Dror Bashan
President and CEO at Protalix BioTherapeutics Inc. (DE)
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Protalix BioTherapeutics Inc. (DE), 3 years.
Protalix BioTherapeutics Inc. (DE)
Director · PRESIDENT AND CEO
Chief executive roles
Protalix BioTherapeutics Inc. (DE)
· President and CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 19, 2025 | Protalix BioTherapeutics Inc. (DE) | Open-market purchase | +56,000 | $1.81 | $101,360 |
| Sep 3, 2025 | Protalix BioTherapeutics Inc. (DE) | Grant or award | +195,000 | — | — |
| Apr 1, 2024 | Protalix BioTherapeutics Inc. (DE) | Grant or award | +263,960 | — | — |
| Oct 19, 2023 | Protalix BioTherapeutics Inc. (DE) | Open-market purchase | +48,387 | $1.40 | $67,742 |
| Oct 19, 2023 | Protalix BioTherapeutics Inc. (DE) | Open-market purchase | +16,129 | $1.41 | $22,742 |
| Aug 15, 2023 | Protalix BioTherapeutics Inc. (DE) | Grant or award | +800,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.